SCHEMBL7549028

SCHEMBL7549028

COc1ccc(-c2cncc(-c3cn(CC(C)CN(C)C)c4cccnc34)c2)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDR P35968 4/20 0.52
FLT1 P17948 1/20 0.52
FLT4 P35916 1/20 0.52
MAOB P27338 2/20 0.37
PDE10A Q9Y233 3/20 0.36
LMNA P02545 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
MAPK1 P28482 1/20 0.35
CHRM2 P08172 1/20 0.35
HTR1A P08908 1/20 0.35
ADRA2A P08913 1/20 0.35
CHRM1 P11229 1/20 0.35
DRD1 P21728 1/20 0.35
TBXA2R P21731 1/20 0.35
PTGS1 P23219 1/20 0.35
ADRA1A P35348 1/20 0.35
OPRM1 P35372 1/20 0.35
DRD3 P35462 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7547036 0.91 FLT1 (0.51) KDRFLT1FLT4MAOBLMNA
SCHEMBL7986720 0.89 KDR (0.59) KDRFLT1FLT4LMNACYP3A4
SCHEMBL7551380 0.89 KDR (0.54) KDRFLT1FLT4PDE10AKCNH2
SCHEMBL7976092 0.86 KDR (0.70) KDRFLT1FLT4LMNACYP1A2
SCHEMBL7555413 0.83 KDR (0.52) KDRFLT1FLT4LMNACYP11B1
SCHEMBL7976803 0.83 KDR (0.75) KDRFLT1FLT4MAOBCYP3A4
SCHEMBL7549825 0.83 KDR (0.51) KDRMAOBPDE10ACYP11B1CYP11B2
SCHEMBL7505010 0.83 KDR (0.58) KDRFLT1FLT4LMNACYP1A2
SCHEMBL7551047 0.83 KDR (0.51) KDRFLT1FLT4MAOBLMNA
SCHEMBL7553739 0.80 KDR (0.54) KDRFLT1FLT4LMNACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1147107-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2002-05-22 EP claimed
EP-1147107-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-10-24 EP claimed
WO-2000043393-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-07-27 WO claimed
EP-1147107-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2002-05-22 EP disclosed
EP-1147107-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-10-24 EP disclosed
US-6265403-B1 TYROSINE INHIBITORS MERCK & CO., INC. 2001-07-24 US disclosed
WO-2000043393-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-07-27 WO disclosed